Piper Sandler adjusted its outlook on Keros Therapeutics (NASDAQ:KROS), significantly reducing the price target from $40.00 ...

Piper Sandler analyst Adam Maeder maintained a Buy rating on Inspire Medical Systems (INSP – Research Report) today and set a price target of ...

In a report released today, Korinne Wolfmeyer from Piper Sandler maintained a Buy rating on Planet Fitness (PLNT – Research Report), with a ...

Piper Sandler named UnitedHealth (NYSE:UNH) and CVS Health (NYSE:CVS) as its top picks in the managed care space, arguing ...

Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of John Kerins as a ...

Piper Sandler Companies is gaining traction with a recovering market. Find out why PIPR stock is becoming an attractive ...

On Monday, Jan. 7, Michael Lavery at Piper Sandler initiated coverage of the beverage giant, with an overweight rating and a ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Piper Sandler estimates that AI/HPC data center contracts could potentially triple miner EBITDA at certain sites. The note ...

LONDON, January 06, 2025--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of Paul Leece, Jeremi Martin and Daniel Allmomen to its energy ...

Piper Sandler downgraded Biogen (NASDAQ:BIIB) to neutral from overweight on Thursday, citing, among other things, the company's challenges in establishing its presence in the market for Alzheimer ...

Despite recent share appreciation, Piper Sandler believes there is still significant upside for Kenvue. “Though shares have ...